“…6 A number of reviews describing pharmacological development and potential for biomedical application of marine natural products have appeared. [7][8][9][10][11][12][13] Many classes of marine-sourced compounds have been reviewed to varying extents, including briarane-type diterpenoids, 14 cyclic polypeptides containing b-amino acid fragments, 15 pyrroloiminoquinone alkaloids, 16 antitumour peptides, 17 cyclic imines including spirolides and gymnodimines, 18 kahalalides, 19 guanidine-containing alkaloids, 20 ascidian-derived alkaloids, 21 2-aminoimidazole alkaloids, 22,23 other assorted alkaloids, 24 carotenoids, 25,26 algal bromophenols, 27 volatile algal halogenated compounds, 28 brominated compounds from Aplysina sponges, 29 furanocembranoids 30 and norcembranoids (from Sinularia sp. ), 31 a-conotoxins, 32 cladiellins, asbestinins and briarellins, 33 and eleutherobins, fuscosides and pseudopterosins.…”